Article
Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.
BMC pediatrics - 1 Jul 2021
Khangura Sara D, Potter Beth K, Davies Christine, Ducharme Robin, Bota A Brianne, Hawken Steven, Wilson Kumanan, Karaceper Maria D, Klaassen Robert J, Little Julian, Simpson Ewurabena, Chakraborty Pranesh
Abstract excerpt
BACKGROUND: Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an opportunity to investigate the potential health implications of carrier status. We aimed to compare rates of health services use among children identified as carriers of hemoglobinopathy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
